Innovent Biologics, Inc. (IVBXF)
USD 4.8
(0.0%)
USD 4.8
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.4 Billion CNY | 3.72% |
| 2022 | 2.31 Billion CNY | 9.69% |
| 2021 | 2.1 Billion CNY | 125.53% |
| 2020 | 935.41 Million CNY | 12.36% |
| 2019 | 832.53 Million CNY | 6.46% |
| 2018 | 782 Million CNY | 54.85% |
| 2017 | 505 Million CNY | 1.0% |
| 2016 | 500 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | 2.97 Billion CNY | 0.0% |
| 2023 Q4 | 2.4 Billion CNY | 0.0% |
| 2023 FY | 2.4 Billion CNY | 3.72% |
| 2023 Q3 | 2.4 Billion CNY | -19.33% |
| 2023 Q1 | 2.97 Billion CNY | 28.57% |
| 2022 Q2 | 1.89 Billion CNY | 0.0% |
| 2022 Q4 | 2.31 Billion CNY | 0.0% |
| 2022 FY | 2.31 Billion CNY | 9.69% |
| 2022 Q1 | 1.89 Billion CNY | -10.31% |
| 2022 Q3 | 2.31 Billion CNY | 22.3% |
| 2021 Q1 | 1.47 Billion CNY | 57.29% |
| 2021 FY | 2.1 Billion CNY | 125.53% |
| 2021 Q4 | 2.1 Billion CNY | 0.0% |
| 2021 Q3 | 2.1 Billion CNY | 43.39% |
| 2021 Q2 | 1.47 Billion CNY | 0.0% |
| 2020 Q2 | 809.4 Million CNY | 0.0% |
| 2020 Q1 | 809.4 Million CNY | -2.78% |
| 2020 FY | 935.41 Million CNY | 12.36% |
| 2020 Q3 | 935.41 Million CNY | 15.57% |
| 2020 Q4 | 935.41 Million CNY | 0.0% |
| 2019 Q2 | 805.61 Million CNY | 0.0% |
| 2019 Q3 | 832.53 Million CNY | 3.34% |
| 2019 Q1 | 805.61 Million CNY | 3.02% |
| 2019 FY | 832.53 Million CNY | 6.46% |
| 2019 Q4 | 832.53 Million CNY | 0.0% |
| 2018 Q2 | 687 Million CNY | -83.79% |
| 2018 FY | 782 Million CNY | 54.85% |
| 2018 Q4 | 782 Million CNY | 0.0% |
| 2018 Q3 | 782 Million CNY | 13.83% |
| 2018 Q1 | 4.23 Billion CNY | 739.03% |
| 2017 Q3 | 3.55 Billion CNY | 0.0% |
| 2017 FY | 505 Million CNY | 1.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q4 | 505 Million CNY | -85.8% |
| 2016 FY | 500 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -170984.242% |
| CSL Limited | 11.23 Billion USD | 78.644% |
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 8000.00 USD | -30002387.5% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -136626.159% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -4092869.203% |
| Mesoblast Limited | 100.29 Million USD | -2293.141% |
| Marizyme, Inc. | 667.12 Thousand USD | -359680.342% |
| Genus plc | 228.2 Million USD | -951.796% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| ContraFect Corporation | 2.21 Million USD | -108506.29% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | -8660.307% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -44131.233% |
| MultiCell Technologies, Inc. | 36.43 USD | -6588523095.169% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -4215.973% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -107725.651% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -195298.503% |
| Biomind Labs Inc. | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -126328.204% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -1401639.765% |
| SQZ Biotechnologies Company | 20.9 Million USD | -11379.263% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -1344.989% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -43544874.601% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -745303.416% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | -15532.402% |
| HST Global, Inc. | - USD | -Infinity% |
| Halberd Corporation | 150 Thousand USD | -1600032.667% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -1461608.84% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -11716.655% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -432688.006% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -9487227.562% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| ONE Bio Corp. | 592.19 Thousand USD | -405203.463% |
| Zenith Capital Corp. | 4456.00 USD | -53864329.982% |
| Genscript Biotech Corporation | 287.12 Million USD | -735.93% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -1900264.998% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -1046691.632% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -1044868.675% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -28944.034% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -903470.313% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 1064.00 USD | -225582512.782% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -1604160.965% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -1604160.965% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -1702168.794% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -3000148.75% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -30593.239% |
| SYBLEU INC | 300 Thousand USD | -799966.333% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -650274.07% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 445 Thousand USD | -539270.562% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -29350.294% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -525107.659% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -206635.487% |
| PureTech Health plc | 18.25 Million USD | -13051.775% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -1600032.667% |
| IXICO plc | 275 Thousand USD | -872699.636% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -20173.663% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -9023.11% |
| CSL Limited | 11.23 Billion USD | 78.644% |
| Cellectis S.A. | 36.21 Million USD | -6528.343% |